Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abscess, intracerebral
acute disseminated encephalomyelitis
adverse drug reaction
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, preclinical
amyloid beta protein
amyloid imaging
amyloid plaques
angiitis, isolated of CNS
anti MAG antibodies
antibodies to myelin basic protein
antimyelin antibodies
asymptomatic
ataxia
autoantibodies
autoimmune disease
axonal degeneration
axonal transection
B cell lymphocytes
Barkhof MR criteria for MS
BCG vaccination
BENEFIT study
biologic markers
brain atrophy
brain biopsy
brain volume
brainstem
brainstem, infarction of
brainstem, lesion of
carcinoma
carcinoma of breast
carotid artery occlusion, intracranial
CAT scan
CAT scan, abnormal
CAT scan, cerebrovascular disease
CAT scan, dense artery sign
CAT scan, early changes in CVA
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, mass effect on
CAT scan, ring sign
central nervous system, infection of
cerebellar infarction
cerebellar lesion
cerebral arteries
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, protein of
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, arterial occlusion, location
cerebrovascular accident, prognosis in
cerebrovascular accident, recurrent
cerebrovascular accident, severity
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular accident, young adult
children
Clinical Pathologic Conference(C.P.C.)
cognition
complications
controversies in neurology
cop 1
corneal dystrophy
corpus callosum
corpus callosum, lesion of
cyclophosphamide
degenerative diseases of CNS
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, presenile
dementia, rapidly progressive
dementia, screening for
demyelinating disease
diabetes insipidus
diagnostic criteria
differential diagnosis
disability rating scale, neurological
disability, neurological
disease modifying agents
efficacy
encephalitis
encephalitis, viral
encephalomyelitis, postinfectious
encephalopathy, Hashimoto's
encephalopathy, metabolic
endovascular therapy
enzyme, defect
Epstein-Barr virus
evoked potentials
Fabry's disease
falling
fever
fibrinolytic agents
fibrinolytic agents, complications
fingolimod
florbetapir
flu-like illness
fourth ventricle, shift of
fumarate
gadolinium
gait disorder
gammaglobulin therapy, intravenous
genetic neurologic disorders
head injury
hearing loss
hearing loss, sudden, unilateral
hemiparesis
heralding manifestation
herpes simplex encephalitis
herpes virus
herpes virus infection
hippocampal atrophy
hippocampus
hydrocephalus
hydrocephalus, exvacuo
hypertension
immunomodulation
immunosuppressive agents
immunotherapy
infection
interferon
interferon beta 1-a
interferon beta 1-b
internal carotid artery
intracerebral hemorrhage
intravenous
ischemic penumbra
Jakob-Creutzfeldt disease
laquinimod
L-dopa
leukoencephalopathy
leukopenia
liver function enzymes
lobar atrophy
Marburg's disease
McDonald criteria for MS
medulla oblongata, infarction of
memory, impairment of
mild cognitive impairment
misdiagnosis
mitoxantrone
monoclonal antibodies
MRI
MRI, abnormal
MRI, ADC maps
MRI, angiography
MRI, cerebrovascular disease
MRI, contrast enhanced
MRI, demyelinating disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, false negative
MRI, fast
MRI, field strength
MRI, field strength, high
MRI, functional
MRI, incidental finding
MRI, lesion burden
MRI, mass effect on
MRI, negative
MRI, optic nerve
MRI, perfusion
MRI, ring sign
MRI, serial
MRI, spinal cord
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, asymptomatic
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, conversion to clinically definite
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, early onset
multiple sclerosis, etiology of
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, MRI conversion
multiple sclerosis, MRI criteria
multiple sclerosis, pathogenesis
multiple sclerosis, preclinical
multiple sclerosis, presenting manifestations
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, secondary progressive
multiple sclerosis, spinal form
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
N-acetyl-L-aspartic acid
natalizumab
neoplasm, intracranial
neoplasm, primary intracerebral
neoplasm, primary intracranial
neoplasm, primary of CNS
neoplasm, primary of CNS-children
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neuropathology
neuroprotective agents
neurosyphilis
NIH stroke scale
nystagmus
ocrelizumab
old age, neurology of
optic nerve, lesion of
optic neuritis
optic neuritis, bilateral
optic neuritis, children
optic neuritis, etiology of
optic neuritis, recurrent
optic neuritis, treatment of
optical coherence tomography
Parkinson disease
Parkinson disease, late onset
Parkinson disease, treatment of
Parkinson disease, young onset
periventricular leukomalacia
Pittsburgh Compound B
placebo
pons, infarction of
posterior cerebral artery territory infarction
posterior fossa
posterior fossa, lesion of
practice guidelines
preclinical
pregnancy, neurologic complications in
prevention of neurologic disorders
prion disease
prognosis
progressive neurologic disorder
protein 14-3-3, cerebrospinal fluid
pseudotumor
rapidly progressing neurologic illness
remote effect of cancer on the nervous system
revascularization, surgical
review article
risk factors
safety
sarcoidosis, CNS
screening
seizure
seizure, children
sensorineural hearing loss
serologic testing
single photon emission computed tomography
slurred speech
somnambulism
spinal cord
spinal cord, enlargement
spinal cord, intramedullary cyst of
spinal cord, lesion of
spinal cord, neoplasm
spinal cord, neoplasm, infants and children
steroid
steroid therapy, CNS treatment and complications with
stroke disability scale
symmetric brain lesions
symptomatic
syphilis, diagnosis and treatment
syphilis, neurologic complications with
syringomyelia
T lesion of MCA-ICA
temporal lobe, atrophy
thyroiditis
tinnitus
tissue plasminogen activator, intravenous
toxic encephalopathy
transient ischemic attack
treatment of neurologic disorder
uremia
urinary incontinence
urinary retention
ventricular enlargement
vertebral-basilar insufficiency
vertigo
vertigo, episodic
viral infection
viral infection, CNS
viral infection, reactivation
visual evoked response
West Nile fever
white matter disease
white matter disease, periventricular
Showing articles 900 to 950 of 4362 << Previous Next >>

Double-Blind, Randomized, Placebo-Controlled Study of Oral, High-Dose Methylprednisolone in Attacks of MS
Neurol 51:529-534, Sellebjerg,F.,et al, 1998

Randomized Trial Comparing Two Different High Doses of Methylprednisolone in MS, A Clinical and MRI Study
Neurol 50:1833-1836, Oliveri,R.L.,et al, 1998

Use of Corticosteroids in Multiple Sclerosis by Consultant Neurologists in the United Kingdom
JNNP 54:362-365, Tremlett,H.L.,et al, 1998

Different Predictors of Neurolgoical Worsening in Different Causes of Stroke
Arch Neurol 55:481-486, Yamamoto,H.,et al, 1998

Craniocerebral Magnetic Resonance Imaging Measurement and Findings in Lesch-Nyhan Syndrome
Arch Neurol 55:547-553, Harris,J.C.,et al, 1998

The Predictive Value of CSF Ologoclonal Banding for MS 5 Years After Optic Neuritis
Neurol 51:885-887, Cole,S.R.,et al, 1998

The Phenotypic Spectrum of CADASIL:Clinical Findings in 102 Cases,
Ann Neurol 44:731-739,715, Dichgans,M.,et al, 1998

Devic's Neuromyelitis Optica:A Prospective Study of Seven Patients Treated with Prednisone and Azathioprine
Neurol 51:1219-1220, Mandler,R.N.,et al, 1998

Interferon B Therapy for Multiple Sclerosis
Lancet 352:1486-1487, Goodkin,D.E., 1998

Interferons in the Treatment of Multiple Sclerosis,Do They Prevent the Progression of the Disease?
Arch Neurol 55:1578-1580,1583, Rice,G.&Ebers,G, 1998

Interferons Should be Used to Treat Most Patients with MS
Arch Neurol 55:1581-1583, Herndon,R.M.&Jacobs,L, 1998

Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998

Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998

Surgical Treatment of Epilepsy in Tuberous Sclerosis,Strategies and Results in 18 Patients
Neurol 51:1263-1269, Guerreiro,M.M.,et al, 1998

Magnetic Resonance Imaging Features of Solitary Inflammatory Brain Masses
J Neuroimag 8:8-14, Bakshi,R.,et al, 1998

Early Structural Changes in Acute MS Lesions Assessed by Serial magnetization Transfer Studies
Neurol 51:1150-1155, Dousset,V.,et al, 1998

Neuropsychiatric Sequelae One Year after a Minor Head Injury
JNNP 65:899-902,809, Deb,S.,et al, 1998

Subdural Haemorrhages in Infants:Population Based Study
BMJ 317:1558-1561,1538, Jayawant,S.,et al, 1998

Clinicopath Conf,Sarcoidosis,with Involvement of Spinal Cord,Brain,Mediastinal Lymph Nodes and ? Lung,Case 35-1998
NEJM 339:1534-1541, , 1998

Clinicopath Conf,Syndrome of Mitochondrial Encephalopathy,Lactic Acidosis,and Stroke-Like Episodes (MELAS),Case 39-1998
NEJM 339:1914-1923, , 1998

A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998

Clinical Approach to Inherited Peroxisomal Disorders: A Series of 27 Patients
Ann Neurol 44:720-730,713, Baumgartner,M.R.,et al, 1998

Amelioration of Flulike Symptoms at the Onset of Interferon B-1b Therapy in Multiple Sclerosis by Low-Dose Oral Steriods is Related to a Decrease in Interleukin-6 Induction
Ann Neurol 44:682-685, Martinez-Caceres,E.M.,et al, 1998

Neutralizing Antibodies to Interferon B-1a and Interferon B-1b in MS Patients are Cross-Reactive
Neurol 51:1698-1702, Khan,O.A. & Dhib-Jalbut,S., 1998

Tolterodine for Overactive Bladder
The Medical Letter 40:101-102, , 1998

Diffusion Magnetic Resonance Imaging in Multiple Sclerosis
JNNP 64:S80-S84, Horsfield,M.A.,et al, 1998

Current Immunotherapy in Multiple Sclerosis
Immunology and Cell Biology 76:55-64, Bashir,K.&Whitaker,J.N., 1998

Physiologic MRI of a Tumefactive Multiple Sclerosis Lesion
Neurol 51:1487-1488, Ernst,T.,et al, 1998

Epilepsy in Patients with Multiple Sclerosis: Radiological-Clinical Correlations
Epilepsia 39:893-896, Moreau,Th.,et al, 1998

Women's Health Issues, Part 1
Med Clin North Am 82:77-101, Belilos,E. & Carsons,S., 1998

Improving Interobserver Variation in Reporting Gadolinium-Enhancing MRI Lesions in Multiple Sclerosis
Neurol 49:1682-1688, Barkhof,F.,et al, 1997

The Quality-of-Life Effects of Interferon Beta-1b in MS
Arch Neurol 54:1475-1480, Schwartz,C.E.,et al, 1997

Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997

Chromosome 19 Single-Locus & Multilocus Haplotype Assoc with MS, Evid of New Suscept Locus in Caucasian & Chinese Pts
JAMA 278:1256-1262, 12821997., Barcellos,L.F.,et al, 1997

Strong Clustering and Stereotyped Nature of Notch3 Mutations, in CADASIL Patients
Lancet 350:1511-1515, 14901997., Joutel,A.,et al, 1997

Clinical Characteristics of Patients with Motor Disability Due to Conversion Disorder:A Prospective Study
JNNP 63:83-88, Binzer,M.,et al, 1997

Clinicopath Conf
Oligodendroglioma, Mixed with Low-Grade Astrocytoma, Multiple Sclerosis, Case 12-1997, NEJM 336:1163, 11717., 1997

Concurrence of Multiple Sclerosis and Brain Tumor:Clinical Considerations
Neurol 48:1330-1333, Khan,O.A.,et al, 1997

Multiple Sclerosis Lesion Detection in the Brain:A Comparison of FLAIR & Conventional T2-Weighted Dual Spin Echo
Neurol 49:364-370, Gawne-Cain,M.L.,et al, 1997

Multiple Sclerosis, Depression, and Suicide
BMJ 315:691-692, Feinstein,A., 1997

Herpes Simplex Encephalitis Treated with Acyclovir:Diagnosis and Long Term Outcome
JNNP 63:321-326, McGrath,N.,et al, 1997

Cerebral Manifestation of Erdheim-Chester Disease:Clinical and Radiologic Findings
Neurol 49:1702-1705, Bohlega,S.,et al, 1997

Idiopathic Granulomatous Angiitis of the CNS Manifesting as Diffuse White Matter Disease
Neurol 49:1696-1699, Finelli,P.F.,et al, 1997

Trigeminal Neuralgia in Patients with Multiple Sclerosis:Lesion Localization with magnetic Resonance Imaging
Neurol 49:1142-1144, Gass,A.,et al, 1997

Myocardial Ischemia with Normal Coronary Arteries Associated with Thoracic Myelitis
NEJM 337:1920, Lalouschek,W.,et al, 1997

A Case-Control and Nerve Biopsy Study of CREST Mutliple Mononeuropathy
Neurol 49:1641-1645, Dyck,P.J.B.,et al, 1997

The 5-Year Risk of MS After Optic Neuritis
Experience of the Optic Neuritis Trtm Trial, Optic Neuritis Study Group, Neurol 49:1404-1413997., , 1997

Volumetric MRI Analysis Comparing Subjects Having Attention-Deficit Hyperactivity Disorder with Normal Controls
Neurol 48:589-601, Filipek,P.A.,et al, 1997

Neuroanatomy in Rett Syndrome:Cerebral Cortex and Posterior Fossa
Neurol 48:399-407, Subramaniam,B.,et al, 1997

Longitudinal Change in Basal Ganglia Volume in Patients with Huntington's Disease
Neurol 48:394-399, Aylward,E.H.,et al, 1997



Showing articles 900 to 950 of 4362 << Previous Next >>